Georgina Buck

BSc, MSc

Medical Statistician, CTSU

Georgina Buck gained a joint honours degree in Mathematics and Psychology at Nottingham University (1991-1994) and a Masters in Statistics with Applications in Medicine at Southampton University (1994-1995) before joining CTSU (now part of NDPH) in 1995. She worked on the Medical Research Council leukaemia trials until their transfer in 2013-2016 and started working on the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial in 2014. She is currently the only statistician who works solely on ASCEND.

Recent publications

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
Journal article

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1540 - 1550
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
Journal article

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
Journal article

Godfrey AL. et al, (2018), J Clin Oncol
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.
Journal article

Bowman L. et al, (2018), Am Heart J, 198, 135 - 144
Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study
Journal article

Eiser C. et al, (2017), PEDIATRIC BLOOD & CANCER, 64

More publications